Ige Olukemi O, Yilgwan Christopher S, Ebonyi Augustine O, Adah Ruth, Adedeji Idris, Yiltok Esther S, Oguche Stephen, Bode-Thomas Fidelia
Department of Paediatrics, University of Jos, Nigeria.
Department of Paediatrics, Jos University Teaching Hospital, Nigeria.
J Virus Erad. 2017 Jul 1;3(3):157-162. doi: 10.1016/S2055-6640(20)30335-6.
To describe the fasting serum lipid and glucose profiles of HIV-positive Nigerian children and determine the prevalence and risk factors for dyslipidaemia and hyperglycaemia, which are risk factors for cardiovascular diseases.
This was a comparative cross-sectional study carried out at the Paediatric Infectious Disease Clinic (PIDC) of the Jos University Teaching Hospital (JUTH) for HIV-positive children and at two primary schools in Jos for HIV-negative children as controls. One hundred and forty-two HIV-positive children aged 6-18 years and an equal number of controls were studied by determining their fasting serum lipid and glucose levels. The prevalence of dyslipidaemia and hyperglycaemia was determined and their risk factors obtained using multivariate logistic regression. values of less than 0.05 were considered statistically significant.
Mean triglyceride levels were significantly higher in HIV-positive children compared with controls at 87.2 mg/dL (95% confidence interval [CI] 79.4-95.0) and 68.1 mg/dL (95% CI 62.5-72.7), respectively (<0.001). There were no significant differences in mean glucose levels. Dyslipidaemia was significantly higher in HIV-positive children (21.8%) compared with controls (12.7%; 0.04). Total serum cholesterol was elevated in 17 (12.0%) HIV-positive participants compared with seven (4.9%) of controls (0.02). Children on lopinavir/ritonavir (LPV/r) and those with no significant or mild disease had a significantly higher prevalence of hypercholesterolaemia (33.3% 4.8% and 14.5% 0.0%, respectively; <0.001).
HIV-positive children on antiretroviral (ARV) drugs, especially LPV/r, should have their lipids regularly monitored as those with dyslipidaemia stand the risk of subsequently developing cardiovascular diseases.
描述尼日利亚HIV阳性儿童的空腹血脂和血糖情况,并确定血脂异常和高血糖的患病率及危险因素,这些都是心血管疾病的危险因素。
这是一项比较性横断面研究,在乔斯大学教学医院(JUTH)的儿科传染病诊所(PIDC)对HIV阳性儿童进行研究,并在乔斯的两所小学选取HIV阴性儿童作为对照。通过测定142名6至18岁的HIV阳性儿童及同等数量对照儿童的空腹血脂和血糖水平进行研究。确定血脂异常和高血糖的患病率,并使用多因素逻辑回归分析其危险因素。P值小于0.05被认为具有统计学意义。
HIV阳性儿童的平均甘油三酯水平显著高于对照组,分别为87.2mg/dL(95%置信区间[CI]79.4 - 95.0)和68.1mg/dL(95%CI 62.5 - 72.7)(P<0.001)。平均血糖水平无显著差异。HIV阳性儿童的血脂异常率(21.8%)显著高于对照组(12.7%;P = 0.04)。与对照组的7名(4.9%)相比,17名(12.0%)HIV阳性参与者的总血清胆固醇升高(P = 0.02)。接受洛匹那韦/利托那韦(LPV/r)治疗的儿童以及无明显疾病或轻度疾病的儿童高胆固醇血症患病率显著更高(分别为33.3%对4.8%和14.5%对0.0%;P<0.001)。
接受抗逆转录病毒(ARV)药物治疗的HIV阳性儿童,尤其是接受LPV/r治疗的儿童,应定期监测血脂,因为血脂异常者有随后发生心血管疾病的风险。